Axial – Talk Bio

Actionable Insights Powered by AI

Hillstar Bio Launches with $67M to Develop Precision Immunotherapies for Autoimmune Diseases

Precision immunology, autoimmune diseases, TRBV9+ T cells, axial spondyloarthritis, Series A funding